X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (52581) 52581
Newsletter (1558) 1558
Newspaper Article (1399) 1399
Book / eBook (189) 189
Book Chapter (187) 187
Magazine Article (99) 99
Dissertation (41) 41
Web Resource (31) 31
Conference Proceeding (24) 24
Publication (7) 7
Book Review (4) 4
Reference (4) 4
Streaming Video (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (47602) 47602
male (28386) 28386
female (27334) 27334
middle aged (23765) 23765
aged (20233) 20233
oncology (19055) 19055
adult (17795) 17795
head (16276) 16276
cancer (16229) 16229
radiotherapy (13120) 13120
head and neck cancer (11837) 11837
surgery (11149) 11149
head and neck neoplasms - radiotherapy (10623) 10623
otorhinolaryngology (9792) 9792
head and neck neoplasms - pathology (9748) 9748
aged, 80 and over (8649) 8649
retrospective studies (7968) 7968
prognosis (7849) 7849
carcinoma, squamous cell - pathology (7738) 7738
squamous cell carcinoma (7581) 7581
chemotherapy (7515) 7515
treatment outcome (7497) 7497
squamous-cell carcinoma (7387) 7387
care and treatment (7355) 7355
head and neck neoplasms - drug therapy (7315) 7315
head and neck neoplasms - therapy (7251) 7251
neck (7212) 7212
radiology, nuclear medicine & medical imaging (6388) 6388
research (6012) 6012
neoplasm staging (5952) 5952
tumors (5942) 5942
neck-cancer (5635) 5635
combined modality therapy (5411) 5411
head and neck neoplasms - surgery (5244) 5244
carcinoma, squamous cell - drug therapy (4837) 4837
analysis (4773) 4773
carcinoma, squamous cell - radiotherapy (4701) 4701
follow-up studies (4688) 4688
carcinoma (4643) 4643
head & neck cancer (4530) 4530
radiation therapy (4483) 4483
radiotherapy dosage (4400) 4400
survival (4351) 4351
radiation-therapy (4174) 4174
metastasis (4040) 4040
medicine & public health (3974) 3974
carcinoma, squamous cell - therapy (3939) 3939
patients (3832) 3832
radiation (3670) 3670
animals (3665) 3665
therapy (3662) 3662
dentistry, oral surgery & medicine (3578) 3578
adolescent (3576) 3576
survival rate (3530) 3530
head and neck neoplasms - mortality (3523) 3523
risk factors (3517) 3517
carcinoma, squamous cell - surgery (3346) 3346
carcinoma, squamous cell - mortality (3328) 3328
hematology, oncology and palliative medicine (3302) 3302
health aspects (3193) 3193
antineoplastic combined chemotherapy protocols - therapeutic use (3067) 3067
squamous cell carcinoma of head and neck (2983) 2983
disease-free survival (2971) 2971
diagnosis (2923) 2923
cell line, tumor (2912) 2912
expression (2893) 2893
head and neck neoplasms - diagnosis (2876) 2876
prospective studies (2853) 2853
survival analysis (2850) 2850
cancer therapies (2830) 2830
oncology, experimental (2816) 2816
lymphatic metastasis (2729) 2729
immunohistochemistry (2697) 2697
time factors (2616) 2616
quality of life (2603) 2603
management (2539) 2539
young adult (2530) 2530
antineoplastic agents - therapeutic use (2507) 2507
head and neck (2496) 2496
head and neck neoplasms - metabolism (2494) 2494
carcinoma, squamous cell - metabolism (2443) 2443
tomography, x-ray computed (2396) 2396
cisplatin (2375) 2375
carcinoma, squamous cell - genetics (2374) 2374
head and neck neoplasms (2373) 2373
mice (2348) 2348
child (2326) 2326
head and neck neoplasms - genetics (2302) 2302
otolaryngology (2299) 2299
medicine (2265) 2265
dentistry (2199) 2199
head and neck neoplasms - diagnostic imaging (2193) 2193
neoplasms (2155) 2155
chemoradiotherapy (2149) 2149
cancer patients (2126) 2126
cisplatin - administration & dosage (2085) 2085
pathology (2038) 2038
medicine, research & experimental (1984) 1984
quality-of-life (1972) 1972
apoptosis (1956) 1956
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (71) 71
Online Resources - Online (27) 27
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
UTL at Downsview - May be requested (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Dentistry (Harry R Abbott) - Stacks (4) 4
Scarborough Hospital - Online (4) 4
St. Michael's Hospital - Stacks (4) 4
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (3) 3
UofT at Mississauga - Stacks (3) 3
Scarborough Hospital - Birchmount (2) 2
St Josephs Health Centre - Stacks (2) 2
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Reserve desk (1) 1
Dentistry (Harry R Abbott) - Circulation Desk (1) 1
Gerstein Science - Course Reserves (1) 1
Lakeridge Health Sciences - Online (1) 1
Providence Healthcare - Reference (1) 1
Trillium Health Centre - Reserve desk (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (53502) 53502
German (1042) 1042
French (718) 718
Japanese (679) 679
Chinese (241) 241
Russian (180) 180
Italian (173) 173
Spanish (165) 165
Polish (155) 155
Portuguese (154) 154
Dutch (51) 51
Hungarian (43) 43
Czech (34) 34
Danish (26) 26
Croatian (21) 21
Serbian (17) 17
Finnish (16) 16
Swedish (15) 15
Turkish (13) 13
Hebrew (12) 12
Norwegian (11) 11
Romanian (7) 7
Greek (4) 4
Korean (3) 3
Ukrainian (3) 3
Slovak (2) 2
Thai (2) 2
Afrikaans (1) 1
Amharic (1) 1
Arabic (1) 1
Chamorro (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Persian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 7, pp. 116 - 117
Background Cancer is a common disease and radiotherapy is one well‐established treatment for some solid tumours... 
'ORPHAN' TOPICS CURRENTLY BEING ADDRESSED | Uterine Cervical Neoplasms | Radiation Tolerance | Neoplasm Recurrence, Local | Techniques to modulate the effects of chemotherapy and/or radiotherapy | Bronchial Neoplasms | Combined Modality Therapy | Urinary Bladder Neoplasms | Head and Neck Neoplasms | Neoplasms | Randomized Controlled Trials as Topic | Rectal Neoplasms | Esophageal Neoplasms | Time Factors | Complementary & alternative medicine | Techniques to modulate the effects of chemotherapy & radiotherapy | Medicine General & Introductory Medical Sciences | Hyperbaric Oxygenation | General cancer treatments | Cancer | Medicine | Evidence | Reprinted from | Abstract | CLINICAL-TRIAL | Humans | Male | Combined Modality Therapy [methods] | NECK-CANCER | RANDOMIZED TRIAL | Bronchial Neoplasms [mortality; radiotherapy] | UTERINE CERVIX | MEDICINE, GENERAL & INTERNAL | Uterine Cervical Neoplasms [mortality; radiotherapy] | Hyperbaric Oxygenation [adverse effects; methods] | Female | Esophageal Neoplasms [mortality; radiotherapy] | Head and Neck Neoplasms [mortality; radiotherapy] | RESEARCH-COUNCIL TRIAL | THERAPY ONCOLOGY GROUP | Rectal Neoplasms [mortality; radiotherapy] | RADIATION-THERAPY | Neoplasm Recurrence, Local [epidemiology] | INTERIM-REPORT | FINAL REPORT | Urinary Bladder Neoplasms [mortality; radiotherapy] | CARCINOMA | Neoplasms [mortality; radiotherapy] | Urinary Bladder Neoplasms - mortality | Bronchial Neoplasms - mortality | Uterine Cervical Neoplasms - radiotherapy | Neoplasms - mortality | Esophageal Neoplasms - radiotherapy | Hyperbaric Oxygenation - adverse effects | Rectal Neoplasms - mortality | Rectal Neoplasms - radiotherapy | Head and Neck Neoplasms - radiotherapy | Bronchial Neoplasms - radiotherapy | Urinary Bladder Neoplasms - radiotherapy | Hyperbaric Oxygenation - methods | Esophageal Neoplasms - mortality | Neoplasms - radiotherapy | Combined Modality Therapy - methods | Neoplasm Recurrence, Local - epidemiology | Head and Neck Neoplasms - mortality | Uterine Cervical Neoplasms - mortality | Index Medicus
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 967 - 975
Abstract Purpose To assess the impact of radiation treatment time (RTT) in head and neck cancers on overall survival (OS... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | CONCURRENT CHEMOTHERAPY | LARYNGEAL-CANCER | THERAPY ONCOLOGY GROUP | SQUAMOUS-CELL CARCINOMA | RANDOMIZED-TRIAL | STANDARD FRACTIONATION | LOCALLY ADVANCED HEAD | 1ST REPORT | PROLONGATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Radiotherapy - mortality | Humans | Oropharyngeal Neoplasms - mortality | Chemoradiotherapy - mortality | Hypopharyngeal Neoplasms - mortality | Tongue Neoplasms - drug therapy | Time Factors | Laryngeal Neoplasms - drug therapy | Tongue Neoplasms - radiotherapy | Tongue Neoplasms - mortality | Chemoradiotherapy - methods | Oropharyngeal Neoplasms - drug therapy | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Oropharyngeal Neoplasms - radiotherapy | Chi-Square Distribution | Tonsillar Neoplasms - mortality | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Analysis of Variance | Laryngeal Neoplasms - mortality | Tonsillar Neoplasms - radiotherapy | Survival Analysis | Tonsillar Neoplasms - drug therapy | Head and Neck Neoplasms - mortality | Hypopharyngeal Neoplasms - drug therapy | Care and treatment | Cancer patients | Radiotherapy | Patient outcomes | Radiation | Cancer | HEAD | PATIENTS | SURVIVAL TIME | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LYMPHATIC SYSTEM | CHEMOTHERAPY | Head and Neck Cancer | Treatment time | National Cancer Database | Squamous Cell
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
... followed by chemoradiotherapy with intensity-modulated radiation therapy (C-IMRT) for head-and-neck cancer patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | SYSTEM | DELINEATION | IMRT | ONCOLOGY | GUIDELINES | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
...) durvalumab in combination with radiotherapy (RT) in an expansion cohort of patients included in a phase 1/2 trial at our institution... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
... [HPV(+)] versus human papillomavirus-unrelated [HPV(−)] head-and-neck cancer (HNC). Methods and Materials All cases of N2-N3 HNC treated with radiation therapy/chemoradiation therapy between 2003 and 2009 were reviewed... 
Radiology | Hematology, Oncology and Palliative Medicine | METASTASIS | ONCOLOGY | DISSECTION | OROPHARYNGEAL CANCER | LYMPH-NODES | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LARYNX | HAZARDS
Journal Article
American journal of clinical oncology, ISSN 0277-3732, 2005, Volume 28, Issue 6, pp. 626 - 630
Purpose: The purpose of this article is to discuss the optimal treatment and outcomes for head and neck mucosal melanoma. Methods... 
Treatment | Radiotherapy | Mucosal melanoma | Outcomes | treatment | ONCOLOGY | outcomes | CAVITY | radiotherapy | mucosal melanoma | MALIGNANT-MELANOMA | TUMORS | RADIATION-THERAPY | Humans | Middle Aged | Male | Nasal Mucosa - pathology | Nose Neoplasms - surgery | Incidence | Paranasal Sinus Neoplasms - surgery | Nose Neoplasms - radiotherapy | Palatal Neoplasms - mortality | Immunotherapy | Aged, 80 and over | Adult | Female | Mouth Neoplasms - radiotherapy | Chemotherapy, Adjuvant | Mouth Mucosa - pathology | Radiotherapy, Adjuvant | Palatal Neoplasms - surgery | Paranasal Sinus Neoplasms - therapy | Nose Neoplasms - pathology | Paranasal Sinus Neoplasms - radiotherapy | Palatal Neoplasms - radiotherapy | Palatal Neoplasms - therapy | Melanoma - radiotherapy | Neoplasm Recurrence, Local | Nose Neoplasms - therapy | Palatal Neoplasms - pathology | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lymphatic Metastasis | Melanoma - pathology | Mouth Neoplasms - mortality | Mouth Neoplasms - therapy | Head and Neck Neoplasms - pathology | Paranasal Sinus Neoplasms - mortality | Head and Neck Neoplasms - radiotherapy | Mucous Membrane - pathology | Paranasal Sinus Neoplasms - pathology | Mouth Neoplasms - surgery | Mouth Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Melanoma - surgery | Neoplasm Staging | Head and Neck Neoplasms - surgery | Melanoma - mortality | Nose Neoplasms - mortality
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2017, Volume 98, Issue 5, pp. 1002 - 1011
To present the long-term and final report of a phase 3 trial designed to assess dose-response relationship for postoperative radiation therapy (PORT... 
SQUAMOUS-CELL-CARCINOMA | SURGERY | IRRADIATION | ONCOLOGY | PHASE-III | LOCALLY ADVANCED HEAD | TIME | RADIOTHERAPY | COMBINATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | CLAVICLES | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Prospective Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - surgery | Male | Oropharyngeal Neoplasms - pathology | Radiotherapy - adverse effects | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Laryngeal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Postoperative Care | Time Factors | Aged, 80 and over | Adult | Female | Mouth Neoplasms - radiotherapy | Radiotherapy Dosage | Laryngeal Neoplasms - surgery | Kaplan-Meier Estimate | Margins of Excision | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Mouth Neoplasms - mortality | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Analysis of Variance | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Mouth Neoplasms - surgery | Mouth Neoplasms - pathology | Aged | Head and Neck Neoplasms - mortality | Dose-Response Relationship, Radiation | Head and Neck Neoplasms - surgery | Cancer patients | Care and treatment | Squamous cell carcinoma | Oncology, Experimental | Radiation | Clinical trials | Head and neck cancer | Research | Radiotherapy | Cancer
Journal Article
International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 291 - 298
Purpose To update the Memorial Sloan-Kettering Cancer Center’s experience with intensity-modulated radiotherapy (IMRT... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Dysphagia | IMRT | Xerostomia | Oropharyngeal cancer | HEAD | CHEMORADIOTHERAPY | NECK-CANCER | RADIATION-THERAPY | SALIVARY FUNCTION | IMPACT | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Pharyngeal Neoplasms - radiotherapy | Follow-Up Studies | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Palate, Soft | Male | Oropharyngeal Neoplasms - pathology | Pharyngeal Neoplasms - drug therapy | Tongue Neoplasms - drug therapy | Incidence | New York City | Palatal Neoplasms - mortality | Treatment Failure | Aged, 80 and over | Adult | Female | Xerostomia - epidemiology | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Tongue Neoplasms - mortality | Tonsillar Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Palatal Neoplasms - radiotherapy | Deglutition Disorders - epidemiology | Palatal Neoplasms - pathology | Oropharyngeal Neoplasms - radiotherapy | Cancer Care Facilities | Tonsillar Neoplasms - mortality | Tongue Neoplasms - pathology | Pharyngeal Neoplasms - mortality | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tonsillar Neoplasms - radiotherapy | Tonsillar Neoplasms - drug therapy | Pharyngeal Neoplasms - pathology | Aged | Palatal Neoplasms - drug therapy | Neoplasm Staging | Radiotherapy, Intensity-Modulated | Care and treatment | Throat cancer | Radiotherapy | Nuclear radiation | Cancer | PATIENTS | NEOPLASMS | FAILURES | METASTASES | PLATINUM | RADIATION DOSES | LYMPHATIC SYSTEM | CHEMOTHERAPY | PLANNING | PHARYNX | TONGUE | WOMEN | MEN | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
Seminars in oncology, ISSN 0093-7754, 2015, Volume 42, Issue 6, pp. 801 - 819
The fibroblast growth factor receptor (FGFR) pathway plays a major role in several biological processes, from organogenesis to metabolism homeostasis and... 
BREAST-CANCER | LUNG-CANCER | IN-VITRO | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | RESISTANCE | GENE AMPLIFICATION | POTENTIAL THERAPEUTIC TARGET | PROGNOSTIC-SIGNIFICANCE | ANTITUMOR-ACTIVITY | EXPRESSION | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Gastrointestinal Neoplasms - drug therapy | Humans | Brain Neoplasms - pathology | Fibroblast Growth Factors - genetics | Brain Neoplasms - metabolism | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Fibroblast Growth Factors - metabolism | Gastrointestinal Neoplasms - pathology | Glioblastoma - genetics | Receptors, Fibroblast Growth Factor - genetics | Female | Glioblastoma - metabolism | Antineoplastic Agents - pharmacology | Molecular Targeted Therapy - methods | Gastrointestinal Neoplasms - metabolism | Biomarkers, Tumor - analysis | Head and Neck Neoplasms - drug therapy | Receptors, Fibroblast Growth Factor - antagonists & inhibitors | Thoracic Neoplasms - pathology | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Thoracic Neoplasms - metabolism | Head and Neck Neoplasms - pathology | Neoplasms - drug therapy | Breast Neoplasms - genetics | Thoracic Neoplasms - genetics | Breast Neoplasms - pathology | Glioblastoma - pathology | Receptors, Fibroblast Growth Factor - metabolism | Head and Neck Neoplasms - genetics | Fibroblast Growth Factors - antagonists & inhibitors | Thoracic Neoplasms - drug therapy | Glioblastoma - drug therapy | Neoplasms - pathology | Drug Resistance, Neoplasm - physiology | Drug Resistance, Neoplasm - drug effects | Index Medicus
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 2016, Volume 66, Issue 5, pp. 408 - 436
... all) anatomic sites of interest to colleagues in various medical specialties, namely, uterine cervix, ovary, breast, lung, head and neck, skin, prostate, bladder, pancreas, and esophagus... 
carcinoma in situ | dysplasia | intraepithelial neoplasia | preinvasive neoplasia | precancer | HIGH-GRADE DYSPLASIA | URINARY-BLADDER | BARRETTS-ESOPHAGUS | HUMAN-PAPILLOMAVIRUS | INTRADUCTAL CARCINOMA | CARCINOMA IN-SITU | PAPILLARY UROTHELIAL HYPERPLASIA | ONCOLOGY | SINGLE ACADEMIC CENTER | TERM-FOLLOW-UP | NECK-CANCER IMPLICATIONS | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Head and Neck Neoplasms - metabolism | Breast Neoplasms - metabolism | Esophageal Neoplasms - pathology | Breast Neoplasms - therapy | American Cancer Society | Uterine Cervical Neoplasms - metabolism | Skin Neoplasms - diagnosis | Urinary Bladder Neoplasms - pathology | Female | Ovarian Neoplasms - metabolism | Uterine Cervical Neoplasms - therapy | Skin Neoplasms - pathology | Prostatic Neoplasms - pathology | Uterine Cervical Neoplasms - diagnosis | Skin Neoplasms - therapy | Carcinoma in Situ - pathology | Ovarian Neoplasms - diagnosis | Pancreatic Neoplasms - pathology | Risk Factors | Head and Neck Neoplasms - therapy | Lung Neoplasms - therapy | Carcinoma in Situ - therapy | Head and Neck Neoplasms - pathology | Skin Neoplasms - metabolism | Breast Neoplasms - pathology | Ovarian Neoplasms - therapy | Head and Neck Neoplasms - diagnosis | Breast Neoplasms - diagnosis | Carcinoma in Situ - diagnosis | Carcinoma in Situ - metabolism | Lung Neoplasms - diagnosis | Population Surveillance | Prevention | Care and treatment | Gastrointestinal system | Practice | Pathologists | Metastasis | Patients | Health aspects | Cervical cancer | Risk factors | Pathology | Usage | Diagnosis | Tumors | Medical diagnosis | Cancer
Journal Article
Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 9, pp. 1566 - 1575
...) patients with nonoropharyngeal (non‐OP) head and neck squamous cell cancers (HNSCCs). METHODS This retrospective, multi... 
human papillomavirus (HPV) | head and neck squamous cell cancer (HNSCC) | p16 | race | sex | oropharyngeal squamous cell cancer (OPSCC) | prognosis | UNITED-STATES | POSITIVE HEAD | IN-SITU HYBRIDIZATION | IMPROVED SURVIVAL | TRIAL | NASOPHARYNGEAL CARCINOMA | HPV STATUS | THERAPY | ONCOLOGY | IMMUNOHISTOCHEMISTRY | Oropharyngeal Neoplasms - ethnology | Head and Neck Neoplasms - virology | Nasopharyngeal Neoplasms - mortality | Prognosis | Asian Americans - statistics & numerical data | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Nasopharyngeal Neoplasms - ethnology | Nasopharyngeal Neoplasms - virology | Oropharyngeal Neoplasms - mortality | Hispanic Americans - statistics & numerical data | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - ethnology | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Mouth Neoplasms - ethnology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - ethnology | Laryngeal Neoplasms - ethnology | Female | Papillomavirus Infections - virology | Retrospective Studies | Repressor Proteins - metabolism | Oncogene Proteins, Viral - metabolism | Ethnic Groups - statistics & numerical data | Papillomavirus Infections - epidemiology | Proportional Hazards Models | European Continental Ancestry Group - statistics & numerical data | Oropharyngeal Neoplasms - virology | Mouth Neoplasms - virology | Mouth Neoplasms - mortality | Human papillomavirus 16 - metabolism | Head and Neck Neoplasms - pathology | African Americans - statistics & numerical data | Papillomavirus E7 Proteins - metabolism | Laryngeal Neoplasms - mortality | Sex Factors | Cyclin-Dependent Kinase Inhibitor p16 - metabolism | Mouth Neoplasms - pathology | Head and Neck Neoplasms - mortality | Neoplasm Staging | DNA, Viral | Human papillomavirus 16 - genetics | Laryngeal Neoplasms - virology | Complications and side effects | Care and treatment | DNA | Head and neck cancer | Research | Papillomavirus infections | Risk factors | Sex | Risk | Population studies | mRNA | Nasopharynx | Human papillomavirus | Race | Larynx | Deoxyribonucleic acid--DNA | Squamous cell carcinoma | Head | Adjustment | Mortality | Health risks | Hazards | Ribonucleic acid--RNA | Minority & ethnic groups | Patients | Survival | Oral cavity | Tobacco | Medical prognosis | Men | Health hazards | Health risk assessment | Hispanics | Cancer | Tumors
Journal Article